Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Gains from Sales and Divestitures (2020 - 2025)

Sanara MedTech's Gains from Sales and Divestitures history spans 6 years, with the latest figure at $140632.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 32.83% year-over-year to $140632.0; the TTM value through Dec 2025 reached $140632.0, up 32.83%, while the annual FY2025 figure was $140632.0, 32.83% up from the prior year.
  • Gains from Sales and Divestitures reached $140632.0 in Q4 2025 per SMTI's latest filing, up from $123591.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $154307.0 in Q4 2022 to a low of $51656.0 in Q1 2024.
  • Average Gains from Sales and Divestitures over 5 years is $103149.3, with a median of $113252.0 recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 154.81% in 2022, then crashed 38.0% in 2023.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $68661.0 in 2021, then surged by 124.74% to $154307.0 in 2022, then fell by 10.75% to $137720.0 in 2023, then dropped by 23.12% to $105875.0 in 2024, then skyrocketed by 32.83% to $140632.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Gains from Sales and Divestitures are $140632.0 (Q4 2025), $123591.0 (Q3 2025), and $113252.0 (Q2 2025).